囊性纤维化中的内分泌紊乱
Endocrine Disorders in Cystic Fibrosis.
作者信息
Blackman Scott M, Tangpricha Vin
机构信息
Division of Pediatric Endocrinology, Department of Pediatrics, Johns Hopkins Hospital, Johns Hopkins University, 200 North Wolfe Street, Baltimore, MD 21287, USA.
Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Atlanta VA Medical Center, Emory University School of Medicine, 101 Woodruff Circle NE, WMRB1301, Atlanta, GA 30322, USA.
出版信息
Pediatr Clin North Am. 2016 Aug;63(4):699-708. doi: 10.1016/j.pcl.2016.04.009.
Abstract
Cystic fibrosis is frequently complicated by endocrine disorders. Diabetes can be expected to affect most with CF and pancreatic insufficiency and varies widely in age of onset, but early identification and treatment improve morbidity and mortality. Short stature can be exacerbated by relative delay of puberty and by use of inhaled corticosteroids. Bone disease in CF causes fragility fractures and should be assessed by monitoring bone mineral density and optimizing vitamin D status. Detecting and managing endocrine complications in CF can reduce morbidity and mortality in CF. These complications can be expected to become more common as the CF population ages.
摘要
囊性纤维化常并发内分泌紊乱。预计大多数患有囊性纤维化且伴有胰腺功能不全的患者会出现糖尿病，其发病年龄差异很大，但早期识别和治疗可改善发病率和死亡率。青春期相对延迟以及使用吸入性糖皮质激素会加剧身材矮小。囊性纤维化患者的骨病会导致脆性骨折，应通过监测骨密度和优化维生素D状态进行评估。检测和管理囊性纤维化患者的内分泌并发症可降低其发病率和死亡率。随着囊性纤维化患者群体的老龄化，这些并发症预计会变得更加常见。
相似文献
1
Endocrine Disorders in Cystic Fibrosis.囊性纤维化中的内分泌紊乱
Pediatr Clin North Am. 2016 Aug;63(4):699-708. doi: 10.1016/j.pcl.2016.04.009.
2
Endocrine complications after solid-organ transplant in cystic fibrosis.囊性纤维化患者实体器官移植后的内分泌并发症。
J Cyst Fibros. 2019 Oct;18 Suppl 2:S111-S119. doi: 10.1016/j.jcf.2019.08.019.
3
[Endocrine complications of cystic fibrosis in childhood].[儿童囊性纤维化的内分泌并发症]
Arch Pediatr. 2012 May;19 Suppl 1:S27-9. doi: 10.1016/S0929-693X(12)71105-3.
4
Endocrine complications of cystic fibrosis.囊性纤维化的内分泌并发症
Adolesc Med. 2002 Feb;13(1):145-59, vii-viii.
5
6
Endocrine Complications of Cystic Fibrosis: A Multisystem Disease of the Endocrine Organs.囊性纤维化的内分泌并发症：一种内分泌器官的多系统疾病。
Semin Respir Crit Care Med. 2019 Dec;40(6):810-824. doi: 10.1055/s-0039-1697917. Epub 2019 Nov 3.
7
Endocrine Complications of Cystic Fibrosis.囊性纤维化的内分泌并发症。
Clin Chest Med. 2022 Dec;43(4):773-789. doi: 10.1016/j.ccm.2022.06.013.
8
Cystic fibrosis bone disease treatment: Current knowledge and future directions.囊性纤维化性骨病的治疗：现有知识和未来方向。
J Cyst Fibros. 2019 Oct;18 Suppl 2:S56-S65. doi: 10.1016/j.jcf.2019.08.017.
9
Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease.晚期囊性纤维化肺病成人患者的骨量与维生素D缺乏
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1892-9. doi: 10.1164/ajrccm.157.6.9712089.
10
How can we prevent multisystem complications of cystic fibrosis?我们如何预防囊性纤维化的多系统并发症？
Semin Respir Crit Care Med. 2007 Jun;28(3):303-11. doi: 10.1055/s-2007-981651.
引用本文的文献
1
Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience.三联CFTR调节剂治疗下小儿囊性纤维化的身高增长速度：一项真实世界单中心经验
J Clin Med. 2025 Jul 25;14(15):5259. doi: 10.3390/jcm14155259.
2
Impact of indoor Air Pollution on the Linear growth of children in Jimma, Ethiopia.室内空气污染对埃塞俄比亚吉马儿童线性生长的影响。
BMC Public Health. 2024 Feb 16;24(1):488. doi: 10.1186/s12889-024-17975-3.
3
Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis.膳食宏量营养素质量与成年囊性纤维化患者的血糖结果相关。
Front Nutr. 2023 Sep 20;10:1158452. doi: 10.3389/fnut.2023.1158452. eCollection 2023.
4
Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.传感器增强型胰岛素泵优化胰岛素治疗对囊性纤维化相关性糖尿病患者血糖控制和身体成分的影响。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1228153. doi: 10.3389/fendo.2023.1228153. eCollection 2023.
5
Prevalence of Low Testosterone in Men With Cystic Fibrosis and Congenital Bilateral Absence of the Vas Deferens: A Cross-sectional Study Using a Large, Multi-institutional Database.患有囊性纤维化和先天性双侧输精管缺失的男性中低睾酮症的患病率：一项使用大型多机构数据库的横断面研究。
Urology. 2023 Dec;182:143-148. doi: 10.1016/j.urology.2023.08.039. Epub 2023 Sep 15.
6
Serum Appetite-Regulating Hormone Levels in Cystic Fibrosis Patients: Influence of the Disease Severity and the Type of Bacterial Infection-A Pilot Study.囊性纤维化患者的血清食欲调节激素水平：疾病严重程度和细菌感染类型的影响——一项初步研究。
Nutrients. 2023 Apr 12;15(8):1851. doi: 10.3390/nu15081851.
7
Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis.囊性纤维化儿童和青少年的体格发育及内分泌特征
J Clin Med. 2022 Jul 13;11(14):4041. doi: 10.3390/jcm11144041.
8
Satisfaction and Concerns with Telemedicine Endocrine Care of Patients with Cystic Fibrosis.囊性纤维化患者远程医疗内分泌护理的满意度与担忧
Telemed Rep. 2022 Mar 21;3(1):93-100. doi: 10.1089/tmr.2021.0053. eCollection 2022.
9
An update on methods for assessing bone quality and health in Cystic fibrosis.囊性纤维化患者骨质量与健康评估方法的最新进展
J Clin Transl Endocrinol. 2021 Dec 6;27:100281. doi: 10.1016/j.jcte.2021.100281. eCollection 2022 Mar.
10
The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.基因修饰因子、炎症和囊性纤维化跨膜传导调节因子在囊性纤维化相关糖尿病发病机制中的作用
J Clin Transl Endocrinol. 2021 Dec 10;27:100287. doi: 10.1016/j.jcte.2021.100287. eCollection 2022 Mar.
本文引用的文献
1
Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.慢性炎症患儿的生长和生长激素-胰岛素样生长因子 1 轴：现有证据、知识空白和未来方向。
Endocr Rev. 2016 Feb;37(1):62-110. doi: 10.1210/er.2015-1026. Epub 2015 Dec 31.
2
CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation.CFTR增强剂疗法可改善患有门控突变的CF患者受损的胰岛素分泌。
J Cyst Fibros. 2016 May;15(3):e25-7. doi: 10.1016/j.jcf.2015.10.012. Epub 2015 Nov 4.
3
Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.囊性纤维化中的骨病：新的致病见解开启新疗法
Osteoporos Int. 2016 Apr;27(4):1401-1412. doi: 10.1007/s00198-015-3343-3. Epub 2015 Oct 2.
4
Treatment of vitamin D deficiency in cystic fibrosis.囊性纤维化中维生素D缺乏的治疗。
J Steroid Biochem Mol Biol. 2016 Nov;164:36-39. doi: 10.1016/j.jsbmb.2015.09.013. Epub 2015 Sep 10.
5
Recombinant growth hormone therapy for cystic fibrosis in children and young adults.重组生长激素治疗儿童和青年成人囊性纤维化
Cochrane Database Syst Rev. 2015 May 20(5):CD008901. doi: 10.1002/14651858.CD008901.pub3.
6
Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex.成年囊性纤维化患者的糖尿病相关死亡率。基因型和性别的作用。
Am J Respir Crit Care Med. 2015 Jan 15;191(2):194-200. doi: 10.1164/rccm.201403-0576OC.
7
Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.内分泌疾病的治疗：囊性纤维化相关性糖尿病：新的发病机制研究为治疗提供新途径。
Eur J Endocrinol. 2015 Apr;172(4):R131-41. doi: 10.1530/EJE-14-0644. Epub 2014 Oct 21.
8
ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents.《2014年国际儿童青少年糖尿病学会临床实践共识指南：儿童及青少年囊性纤维化相关糖尿病的管理》
Pediatr Diabetes. 2014 Sep;15 Suppl 20:65-76. doi: 10.1111/pedi.12178.
9
Resolution of cystic fibrosis-related diabetes with ivacaftor therapy.依伐卡托治疗使囊性纤维化相关糖尿病得到缓解。
Am J Respir Crit Care Med. 2014 Sep 1;190(5):590-1. doi: 10.1164/rccm.201405-0882LE.
10
Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.尽管胰岛细胞数量未减少，但囊性纤维化猪的血糖调节和胰岛素分泌仍存在异常。
Clin Sci (Lond). 2015 Jan;128(2):131-42. doi: 10.1042/CS20140059.
Zotero 插件